Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Stem Cells (Dayton, Ohio)
|
August 9, 2014
Myb permits multilineage airway epithelial cell differentiation
Jie-Hong Pan, Tracy L Adair-Kirk, Anand C Patel, et al.
Molecular Cancer
|
June 7, 2021
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
Chi Yan, Nabil Saleh, Jinming Yang, et al.
Genes & Cancer
|
August 19, 2010
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition
Shashidhar S Jatiani, Stephen C Cosenza, M V Ramana Reddy, et al.
Cancer Research
|
February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma
Deepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Journal of Medicinal Chemistry
|
June 12, 2013
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents
M V Ramana Reddy, Muralidhar R Mallireddigari, Venkat R Pallela, et al.
The Journal of Biological Chemistry
|
August 27, 2010
Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome
Zhi-Xing Yao, Wilma Jogunoori, Sanaa Choufani, et al.
Hepatology (Baltimore, Md.)
|
April 27, 2011
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer
Hye Jung Baek, Michael J Pishvaian, Yi Tang, et al.
Cell Reports. Medicine
|
July 8, 2025
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer
Shalini Nath, Sally Claridge, Genesis Lara Granados, et al.
Nature Communications
|
August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Journal of Medicinal Chemistry
|
January 15, 2014
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)
M V Ramana Reddy, Balireddy Akula, Stephen C Cosenza, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Stem Cells (Dayton, Ohio)
|
August 9, 2014
Myb permits multilineage airway epithelial cell differentiation
Jie-Hong Pan, Tracy L Adair-Kirk, Anand C Patel, et al.
Molecular Cancer
|
June 7, 2021
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
Chi Yan, Nabil Saleh, Jinming Yang, et al.
Genes & Cancer
|
August 19, 2010
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition
Shashidhar S Jatiani, Stephen C Cosenza, M V Ramana Reddy, et al.
Cancer Research
|
February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma
Deepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Journal of Medicinal Chemistry
|
June 12, 2013
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents
M V Ramana Reddy, Muralidhar R Mallireddigari, Venkat R Pallela, et al.
The Journal of Biological Chemistry
|
August 27, 2010
Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome
Zhi-Xing Yao, Wilma Jogunoori, Sanaa Choufani, et al.
Hepatology (Baltimore, Md.)
|
April 27, 2011
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer
Hye Jung Baek, Michael J Pishvaian, Yi Tang, et al.
Cell Reports. Medicine
|
July 8, 2025
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer
Shalini Nath, Sally Claridge, Genesis Lara Granados, et al.
Nature Communications
|
August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Journal of Medicinal Chemistry
|
January 15, 2014
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)
M V Ramana Reddy, Balireddy Akula, Stephen C Cosenza, et al.
Page
of 10